Cart
sales@molnova.com
Ataquimast
CAS No. 182316-31-0
Ataquimast( —— )
Catalog No. M27960 CAS No. 182316-31-0
Ataquimast is used in curing advanced receptor-positive breast cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 119 | In Stock |
|
| 5MG | 131 | In Stock |
|
| 10MG | 199 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 442 | In Stock |
|
| 100MG | 593 | In Stock |
|
| 200MG | 775 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtaquimast
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtaquimast is used in curing advanced receptor-positive breast cancer.
-
DescriptionAtaquimast is used in curing advanced receptor-positive breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGCN2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number182316-31-0
-
Formula Weight203.245
-
Molecular FormulaC11H13N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCn1c2ccccc2nc(NC)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dieter Dorsch, et al. Triazolo[4,5-d]pyrimidine derivatives. WO2013110309A1.
molnova catalog
related products
-
L-Histidine benzyl e...
L-Histidine benzyl ester bistosylate could play a role in the activation of HutP (an RNA-binding protein) .
-
ACT-389949
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.
-
Amifostine trihydrat...
Amifostine is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
